Milan-based XGEN Venture - a newly formed Venture Capital firm - has reached a first close of its debut life sciences fund on €160 million. The firm is looking to make venture investments in as many as 15 companies over the lifecycle of the fund.

The firm says a good portion of XGEN-backed companies will be formed from technologies originated in Itali